Protein kinase C-δ mediates sepsis-induced activation of complement 5a and urokinase-type plasminogen activator signaling in macrophages

Inflammation Research

Volumn 63, Issue 7, 2014, Pages 581-589

  Yang, Xiao Song ^a,b   Liu, Meng Yuan ^a   Zhang, Hai Mou ^a   Xue, Bing Zhong ^b   Shi, Hang ^b   Liu, Dong Xu ^a  

^a HUBEI UNIVERSITY   (China)

^b GEORGIA STATE UNIVERSITY   (United States)

Author keywords

C5a; Macrophage; PKC ; Sepsis; uPA

Indexed keywords

COMPLEMENT COMPONENT C5A; MESSENGER RNA; PROTEIN KINASE C DELTA; PROTEIN KINASE TYK2; ROTTLERIN; STAT3 PROTEIN; UROKINASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; C57BL 6 MOUSE; CECAL LIGATION PUNCTURE; CONTROLLED STUDY; FEMALE; INNATE IMMUNITY; LIGATION; MALE; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; POLYMERASE CHAIN REACTION; PROTEIN EXPRESSION; PUNCTURE; QUANTITATIVE STUDY; RNA ISOLATION; SEPSIS; ANIMAL; C57BL MOUSE; CELL CULTURE; GENETICS; IMMUNOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; COMPLEMENT C5A; FEMALE; MACROPHAGES, PERITONEAL; MALE; MICE, INBRED C57BL; PROTEIN KINASE C-DELTA; SEPSIS; SIGNAL TRANSDUCTION; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84902649889     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-014-0729-1     Document Type: Article

References (29)

1. Czermak BJ, Sarma V, Pierson CL, Warner RL, Huber-Lang M, Bless NM, et al. Protective effects of C5a blockade in sepsis. Nat Med. 1999;5:788-92. (Pubitemid 29318613)
2. Guo RF, Huber-Lang M, Wang X, Sarma V, Padgaonkar VA, Riedemann NC, et al. Protective effects of anti-C5a in sepsis-induced thymocyte apoptosis. J Clin Invest. 2000;106:1271-80.
3. Huber-Lang M, Sarma VJ, Lu KT, McGuire SR, Padgaonkar VA, Guo RF, et al. Role of C5a in multiorgan failure during sepsis. J Immunol. 2001;166:1193-9. (Pubitemid 32060279)
4. Smedegard G, Cui LX, Hugli TE. Endotoxin-induced shock in the rat. a role for C5a. Am J Pathol. 1989;135:489-97. (Pubitemid 19246207)
5. Ward PA, Guo RF, Riedemann NC. Manipulation of the complement system for benefit in sepsis. Crit Care Res Pract. 2012;. doi:10.1155/2012/427607.
6. Riedemann NC, Guo RF, Ward PA. A key role C5a/C5aR activation for the development of sepsis. J Leukoc Biol. 2003;74:966-70. (Pubitemid 38040317)
7. Monk PN, Sola AM, Madala P, Fairlie DP. Function, structure and therapeutic potential of complement C5a receptors. Br J Pharmacol. 2007;152:429-48. (Pubitemid 47585036)
8. Zhang H, Qin G, Liang G, Li J, Barrington RA, Liu DX. C5aR-mediated myocardial ischemia/reperfusion injury. Biochem Biophys Res Commun. 2007;357:446-52. (Pubitemid 46603152)
9. Hansen AP, Petros AM, Meadows RP, Nettesheim DG, Mazar AP, Olejniczak ET, et al. Solution structure of the amino-terminal fragment of urokinase-type plasminogen activator. Biochemistry. 1994;33:4847-64. (Pubitemid 24158434)
10. May AE, Kanse SM, Lund LR, Gisler RH, Imhof BA, Preissner KT. Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo. J Exp Med. 1998;188:1029-37. (Pubitemid 28443326)
11. Rijneveld AW, Levi M, Florguin S, Speelman P, Carmeliet P, Van Der Poll T. Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia. J Immunol. 2002;168:3507-11. (Pubitemid 34250418)
12. Fuhrman B, Nitzan O, Karry R, Volkova N, Dumler I, Aviran M. Urokinase plasminogen activator (uPA) stimulates cholesterol biosynthesis in macrophagesthrough activation of SREBP-1 in a PI3-kinase and MEK-dependent manner. Atherosclerosis. 2007;195:108-16.
13. Blasi F, Carmeliet P. uPAR: a versatile signalling orchestrator. Nat Rev Mol Cell Biol. 2002;3:932-43. (Pubitemid 35477371)
14. Gyetko MR, Chen GH, McDonald RA, Goodman R, Huffnagle GB, Wilkinson CC, et al. Urokinase is required for the pulmonary inflammatory response to Cryptococcus neoformans. a murine transgenic model. J Clin Invest. 1996;97:1818-26.
15. Gyetko MR, Sud S, Kendall T, Fuller JA, Newstead MW, Standiford TJ. Urokinase receptor-deficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection. J Immunol. 2000;165:1513-9. (Pubitemid 30604586)
16. Mondino A, Blasi F. uPA and uPAR in fibrinolysis, immunity and pathology. Trends Immunol. 2004;25:450-5. (Pubitemid 38951087)
17. Abraham E, Gyetko MR, Kuhn K, Arcaroli J, Strassheim D, Park JS, et al. Urokinase-type plasminogen activator potentiates lipopolysaccharide-induced neutrophil activation. J Immunol. 2003;170:5644-51. (Pubitemid 36617856)
18. Morrison DC, Kline LF. Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS). J Immunol. 1977;118:362-8. (Pubitemid 8028552)
19. Ando Y, Jensen PJ. Protein kinase C mediates upregulation of urokinase and its receptor in the migrating keratinocytes of wounded cultures, but urokinase is not required for movement across a substratum in vitro. J Cell Physiol. 1996;167:500-11. (Pubitemid 26168226)
20. Monick MM, Carter AB, Flaherty DM, Peterson MW, Hunninghake GW. Protein kinase C zeta plays a central role in activation of the p42/44 mitogen-activated protein kinase by endotoxin in alveolar macrophages. J Immunol. 2000;165:4632-9.
21. Zhang D, Anantharam V, Kanthasamy A, Kanthasamy AG. Neuroprotective effect of protein kinase C delta inhibitor rottlerin in cell culture and animal models of Parkinson's disease. J Pharmacol Exp Ther. 2007;322:913-22. (Pubitemid 47295809)
22. Yan C, Gao H. New insights for C5a and C5a receptors in sepsis. Front Immunol. 2012;. doi:10.3389/fimmu.2012.00368.
23. Puyo CA, Dahms TE. Innate immunity mediating inflammation secondary to endotracheal intubation. Arch Otolaryngol Head Neck Surg. 2012;138:854-8.
24. Han G, Geng S, Li Y, Chen G, Wang R, Li X, et al. γδT-cell function in sepsis is modulated by C5a receptor signaling. Immunology. 2011;133:340-9.
25. Knoop A, Andreasen PA, Andersen JA, Hansen S, Laenkholm AV, Simonsen AC, et al. Prognostic significance of urokinasetype plasminogen activator and plasminogen activator inhibitor-1 in primary breast cancer. Br J Cancer. 1998;77:932-40. (Pubitemid 28101782)
26. Jo M, Takimoto S, Montel V, Gonias SL. The urokinase receptor promotes cancer metastasis independently of urokinase-type plasminogen activator in mice. Am J Pathol. 2009;175:190-200.
27. Gschwendt M, Muller HJ, Kielbassa K, Zang R, Kittstein W, Rincke G, Marks F. Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun. 1994;199(1):93-8. (Pubitemid 24179919)
28. Davies SP, Reddy H, Caivano M, Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem J. 2000;35(Pt1):95-105.
29. Choi YH, Jin GY, Li LC, Yan GH. Inhibition of protein kinase C delta attenuates allergic airway inflammation through suppression of PI3K/Akt/mTOR/HIF-1 alpha/VEGF pathway. PLoS One. 2013;8(11):e81773.